Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07185828 · ClinicalTrials.gov registry record · NA
Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)
A NA study of Emergency Service, Hospital and Behavior Change Interventions, sponsored by Geisinger Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 8,286
- Enrollment target
- 1
- Study location
NCT07185828: Recruiting NA study of Emergency Service, Hospital and Behavior Change Interventions, sponsored by Geisinger Clinic.
NCT07185828 is a NA study of Emergency Service, Hospital and Behavior Change Interventions that is actively recruiting participants, run by Geisinger Clinic. The registered enrollment target is 8,286 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (491% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07185828, a NA study of Emergency Service, Hospital and Behavior Change Interventions, is actively recruiting participants, sponsored by Geisinger Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 8,286 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this campaign is to reduce unnecessary visits to a Geisinger emergency department (ED). In this campaign, patients will be assigned to receive or not receive outreach following ED discharge with a low-acuity visit designation. Outreach will occur via a text message the day after discharge from the ED as well as information added to the patient's after visit summary (AVS). Depending on the assigned condition, it will include calls to see their primary care provider (PCP) or use an Intelligent Triage tool. The study will assess whether ED use within the following 120 days differs across patients in different outreach conditions (current standard practice vs contact your PCP vs use Intelligent Triage). It will also examine whether patients follow through on the message-specific calls to action differently across conditions.
Primary Outcome
ED visit (yes/no)
Conditions Studied
Interventions
- BEHAVIORAL Contact your PCP
- BEHAVIORAL Use Intelligent Triage
Study Locations (1)
Pennsylvania
- Geisinger - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,286 participants |
| Start Date | 2025-04-15 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT07185828 shows while recruiting
NCT07185828 is an interventional study that assigns participants to a tested intervention. Its 8,286 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (491% higher).
The record links to 2 conditions, with Emergency Service, Hospital appearing as the primary indexed condition, and to 2 interventions - of which Contact your PCP is the first listed.
NCT07185828 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07185828 about?
NCT07185828 is a clinical study titled "Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)". The goal of this campaign is to reduce unnecessary visits to a Geisinger emergency department (ED). In this campaign, patients will be assigned to receive or not receive outreach following ED discharge with a low-acuity visit designation. Outreach will occur via a text message the day after discharg...
What is the current status of trial NCT07185828?
This trial is currently recruiting. It is a NA study. The enrollment target is 8,286 participants. The study started on 2025-04-15. Estimated completion is 2026-08.
What conditions does trial NCT07185828 study?
This clinical trial studies the following conditions: Emergency Service, Hospital, Behavior Change Interventions.
What interventions are being tested in trial NCT07185828?
The interventions under investigation include: Contact your PCP (BEHAVIORAL), Use Intelligent Triage (BEHAVIORAL).
Who is sponsoring clinical trial NCT07185828?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07185828 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emergency Service, Hospital
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07185828's enrollment target sits among peer trials
8,286 18th of 2000 higher than 1,983 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06435806 · 8,200 participants · NA
Medical Illustration Design Characteristic Evaluation
- NCT06184945 · 8,100 participants · NA
Behavioral Economic & Staffing Strategies in the ICU
- NCT05593484 · 8,060 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI